PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY

PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY

Show other versions (1)

Objective: to study the prognostic value of alterations in the VHL gene and the plasma markers hVEGF, hVEGFR2, and hVEGFR3 in patients with metastatic kidney cancer (KC) who receive targeted therapy.Subjects and methods. Paraffin blocks from 22 patients with metastatic KC who received targeted thera...

Full description

Bibliographic Details
Main Authors: M. V. Peters, V. E. Shevchenko, V. B. Matveev, M. I. Volkova, S. A. Kalinin, D. M. Mikhailenko, D. V. Zaletayev
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
targeted therapy
vhl gene alterations
plasma markers
prognostic value
Online Access:https://oncourology.abvpress.ru/oncur/article/view/185

Internet

https://oncourology.abvpress.ru/oncur/article/view/185

Similar Items